Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Drug Therapy, Combination"" wg kryterium: Temat


Tytuł:
Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study.
Autorzy:
Cabanilla MG; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.; Department of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Bernauer ML; RS21, Albuquerque, New Mexico, United States of America.
Atallah LM; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Briski MJ; Department of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Koury J; Department of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Thompson CM; TriCore Reference Laboratories, Albuquerque, New Mexico, United States of America.
Rodriguez CN; Department of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Jakeman B; Department of Pharmacy Practice and Administrative Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, United States of America.
Byrd TF; Division of Infectious Diseases, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 May 20; Vol. 19 (5), pp. e0304103. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*/drug effects
Ceftaroline*
Bacteremia*/drug therapy
Bacteremia*/microbiology
Bacteremia*/mortality
Anti-Bacterial Agents*/therapeutic use
Anti-Bacterial Agents*/administration & dosage
Staphylococcal Infections*/drug therapy
Staphylococcal Infections*/microbiology
Staphylococcal Infections*/mortality
Cephalosporins*/therapeutic use
Cephalosporins*/administration & dosage
Drug Therapy, Combination*
Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
Autorzy:
van Dijk BT; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands. B.T.van_.; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands. B.T.van_.
Bergstra SA; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands.
van den Berg JM; Department of Paediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands.
Schonenberg-Meinema D; Department of Paediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands.
van Suijlekom-Smit LWA; Department of Paediatric Rheumatology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, the Netherlands.
van Rossum MAJ; Department of Paediatrics, Emma Children's Hospital / Amsterdam University Medical Centres, Amsterdam, the Netherlands.; Department of Paediatric Rheumatology, Amsterdam Rheumatology and Immunology Centre (Reade), Amsterdam, the Netherlands.
Koopman-Keemink Y; Department of Paediatrics, Juliana Children's Hospital / HagaZiekenhuis, the Hague, the Netherlands.
Ten Cate R; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands.
Allaart CF; Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands.
Brinkman DMC; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands.
Hissink Muller PCE; Department of Paediatrics - division of Paediatric Rheumatology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, the Netherlands.
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 May 10; Vol. 22 (1), pp. 53. Date of Electronic Publication: 2024 May 10.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Arthritis, Juvenile*/drug therapy
Etanercept*/administration & dosage
Etanercept*/therapeutic use
Etanercept*/adverse effects
Antirheumatic Agents*/administration & dosage
Antirheumatic Agents*/therapeutic use
Methotrexate*/administration & dosage
Methotrexate*/therapeutic use
Drug Therapy, Combination*
Humans ; Female ; Male ; Child ; Child, Preschool ; Dose-Response Relationship, Drug ; Treatment Outcome ; Prednisolone/administration & dosage ; Sulfasalazine/administration & dosage ; Sulfasalazine/therapeutic use
Czasopismo naukowe
Tytuł:
Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
Autorzy:
Tsukadaira T; Department of Internal Medicine, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan. .
Hayashi S; Department of Pathology, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan.
Ota H; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, 3-1-1, Asahi, 390-8621, Matsumoto, Japan.
Kobayashi N; Department of Internal Medicine, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan.
Agawa H; Department of Internal Medicine, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan.
Kodaira H; Department of Pathology, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan.
Sekiguchi Y; Department of Internal Medicine, Kenwakai Hospital, Kanaenakadaira, Iida, 1936, 395-0801, Japan.
Matsumoto T; Department of Laboratory Sciences, Gumma University Graduate School of Health, 3-39-22 Showa-cho, Maebashi, 371-8511, Japan.
Horiuchi K; Department of Laboratory Medicine, Shinshu University Hospital, 3-1-1, Asahi, 390-8621, Matsumoto, Japan.
Negishi T; Department of Laboratory Medicine, Shinshu University Hospital, 3-1-1, Asahi, 390-8621, Matsumoto, Japan.
Tada T; Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, 1-12-1 Shimoteno, 670-8540, Himeji, Japan.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 May 08; Vol. 24 (1), pp. 157. Date of Electronic Publication: 2024 May 08.
Typ publikacji:
Journal Article; Clinical Study
MeSH Terms:
Proton Pump Inhibitors*/administration & dosage
Proton Pump Inhibitors*/therapeutic use
Helicobacter Infections*/drug therapy
Helicobacter Infections*/microbiology
Drug Therapy, Combination*
Anti-Bacterial Agents*/administration & dosage
Anti-Bacterial Agents*/therapeutic use
Gastritis*/drug therapy
Gastritis*/microbiology
Helicobacter heilmannii*/isolation & purification
Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Helicobacter pylori/drug effects ; Helicobacter pylori/isolation & purification ; Amoxicillin/administration & dosage ; Amoxicillin/therapeutic use ; Clarithromycin/administration & dosage ; Clarithromycin/therapeutic use ; Helicobacter/isolation & purification ; Helicobacter/drug effects ; Treatment Outcome ; Gastric Mucosa/microbiology ; Gastric Mucosa/pathology
Czasopismo naukowe
Tytuł:
Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non-segmental vitiligo.
Autorzy:
Zartab H; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.; Taleghani Hospital, Urmia University of Medical Sciences, Urmia, Iran.
Aflatoonian M; Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.
Shamsi-Meymandi S; Pathology and Stem Cells Research Center, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Pardakhty A; Neuropharmacology Institute, Pharmaceutics Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Isazadeh A; Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Firooz A; Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Amiri R; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Jun; Vol. 23 (6), pp. 2103-2108. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Vitiligo*/drug therapy
Atorvastatin*/administration & dosage
Tacrolimus*/administration & dosage
Calcineurin Inhibitors*/administration & dosage
Ointments*/administration & dosage
Drug Therapy, Combination*/methods
Humans ; Female ; Adult ; Male ; Young Adult ; Treatment Outcome ; Pilot Projects ; Patient Satisfaction ; Administration, Cutaneous ; Middle Aged ; Liposomes ; Severity of Illness Index ; Adolescent ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage
Czasopismo naukowe
Tytuł:
A meta-analysis of efficacy on dexamethasone and clomiphene in the treatment of polycystic ovary syndrome patients.
Autorzy:
Sha Y; Department of Obstetrics and Gynecology, Zhangjiagang Second People's Hospital, Zhangjiagang City, Jiangsu Province, China.
Zhu J; Department of Obstetrics and Gynecology, Zhangjiagang Second People's Hospital, Zhangjiagang City, Jiangsu Province, China.
Shen F; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Suzhou University, Suzhou City, Jiangsu Province, China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 May 20; Vol. 24 (1), pp. 298. Date of Electronic Publication: 2024 May 20.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Polycystic Ovary Syndrome*/drug therapy
Clomiphene*/therapeutic use
Dexamethasone*/therapeutic use
Fertility Agents, Female*/therapeutic use
Humans ; Female ; Pregnancy ; Drug Therapy, Combination ; Treatment Outcome ; Pregnancy Rate
Czasopismo naukowe
Tytuł:
Comparison of the effect of Everolimus, Prednisolone, and a combination of both on experimentally induced peritoneal adhesions in rats.
Autorzy:
Kazemi K; Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Jamshidi K; Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran.
Naseri R; Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shahriarirad R; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran.; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shamsaeefar A; Shiraz Transplant Center, Abu Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Hosseinzadeh A; Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran. .; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 May 14; Vol. 14 (1), pp. 11077. Date of Electronic Publication: 2024 May 14.
Typ publikacji:
Journal Article; Comparative Study
MeSH Terms:
Everolimus*/pharmacology
Everolimus*/administration & dosage
Prednisolone*/pharmacology
Prednisolone*/administration & dosage
Animals ; Tissue Adhesions/drug therapy ; Tissue Adhesions/prevention & control ; Tissue Adhesions/pathology ; Rats ; Male ; Drug Therapy, Combination ; Disease Models, Animal ; Peritoneum/pathology ; Peritoneum/drug effects ; Peritoneal Diseases/drug therapy ; Peritoneal Diseases/pathology ; Peritoneal Diseases/prevention & control ; Peritoneal Diseases/etiology ; Postoperative Complications/prevention & control ; Postoperative Complications/drug therapy
Czasopismo naukowe
Tytuł:
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Autorzy:
Sharma R; Global Health Medicines R&D, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
Sharma H; GSK, Brentford, Middlesex, UK.
Jones S; GSK, Brentford, Middlesex, UK.
Borghini-Fuhrer I; Medicines for Malaria Venture, Geneva, Switzerland.
Domingo GJ; PATH, Seattle, WA, USA.
Gibson RA; Global Health Medicines R&D, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. .
Rolfe K; Global Health Medicines R&D, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
Tan L; GSK, Brentford, Middlesex, UK.
Fiţa IG; GSK, Brentford, Middlesex, UK.
Chen C; GSK, Brentford, Middlesex, UK.
Bird P; GSK, Brentford, Middlesex, UK.
Pingle A; GSK, Mumbai, India.
Duparc S; Medicines for Malaria Venture, Geneva, Switzerland.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2024 May 13; Vol. 23 (1), pp. 145. Date of Electronic Publication: 2024 May 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Malaria, Vivax*/drug therapy
Aminoquinolines*/administration & dosage
Aminoquinolines*/adverse effects
Aminoquinolines*/therapeutic use
Antimalarials*/therapeutic use
Antimalarials*/administration & dosage
Antimalarials*/adverse effects
Humans ; Primaquine/administration & dosage ; Primaquine/therapeutic use ; Primaquine/adverse effects ; Risk Assessment ; Treatment Outcome ; Drug Therapy, Combination ; Plasmodium vivax/drug effects ; Chloroquine/therapeutic use ; Chloroquine/adverse effects ; Chloroquine/administration & dosage
Czasopismo naukowe
Tytuł:
Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity.
Autorzy:
Cuatrecasas G; CP Endocrinologia SLP, 08037, Barcelona, Spain. .; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain. .; Facultat Ciencies Salut, Open University Catalonia (UOC), Barcelona, Spain. .
De Cabo F; Ultrasound Department, Institut Guirado for Radiology, Barcelona, Spain.
Coves MJ; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Patrascioiu I; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Aguilar G; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Cuatrecasas G; CP Endocrinologia SLP, 08037, Barcelona, Spain.; EAP Sarrià, Barcelona, Spain.
March S; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Calbo M; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Rossell O; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Balfegó M; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Benito C; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Di Gregorio S; CP Endocrinologia SLP, 08037, Barcelona, Spain.; Center for Obesity Management EASO, Clinica Sagrada Familia, Barcelona, Spain.
Garcia Lorda P; Facultat Ciencies Salut, Open University Catalonia (UOC), Barcelona, Spain.; Cognitive NeuroLab, Barcelona, Spain.
Muñoz E; Facultat Ciencies Salut, Open University Catalonia (UOC), Barcelona, Spain.; Cognitive NeuroLab, Barcelona, Spain.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 May 11; Vol. 14 (1), pp. 10832. Date of Electronic Publication: 2024 May 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Randomized Controlled Trial; Clinical Trial, Phase IV
MeSH Terms:
Metformin*/therapeutic use
Metformin*/pharmacology
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/metabolism
Glucosides*/therapeutic use
Glucosides*/pharmacology
Obesity*/drug therapy
Obesity*/complications
Benzhydryl Compounds*/therapeutic use
Benzhydryl Compounds*/pharmacology
Humans ; Female ; Male ; Middle Aged ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors/pharmacology ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology ; Aged ; Drug Therapy, Combination ; Adult
Czasopismo naukowe
Tytuł:
Low-dose short infusion ketamine as adjunct to morphine for acute long bone fracture in the emergency department: a randomized controlled trial.
Autorzy:
Eddie EA; Department of Emergency Medicine, Emergency and Trauma Department, Hospital Tawau, 91007, Tawau, Sabah, Malaysia.
Zahedi AZBA; Department of Emergency Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Wilayah Persekutuan, Malaysia.
Jamaluddin SFB; Department of Emergency Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, 47000, Sungai Buloh, Selangor, Malaysia. .
Noor JM; Department of Emergency Medicine, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, 47000, Sungai Buloh, Selangor, Malaysia. .
Pokaż więcej
Źródło:
BMC emergency medicine [BMC Emerg Med] 2024 May 09; Vol. 24 (1), pp. 80. Date of Electronic Publication: 2024 May 09.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Ketamine*/administration & dosage
Morphine*/administration & dosage
Emergency Service, Hospital*
Analgesics, Opioid*/administration & dosage
Fractures, Bone*
Humans ; Female ; Male ; Middle Aged ; Single-Blind Method ; Adult ; Infusions, Intravenous ; Analgesics/administration & dosage ; Pain Measurement ; Drug Therapy, Combination ; Pain Management/methods ; Aged
Czasopismo naukowe
Tytuł:
Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China.
Autorzy:
Wang L; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China.
Huo X; Department of Hepatological Surgery, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China.
Sun H; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China.
Liu F; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China.
Huang R; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China. .
Zhao Q; Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong Province, 264000, China. zhaoquan_.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 May 09; Vol. 24 (1), pp. 1275. Date of Electronic Publication: 2024 May 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/drug therapy
Heart Failure*/mortality
Heart Failure*/economics
Cost-Benefit Analysis*
Markov Chains*
Pyrimidines*/therapeutic use
Pyrimidines*/economics
Stroke Volume*
Humans ; China ; Chronic Disease/drug therapy ; Drug Therapy, Combination ; Quality-Adjusted Life Years ; Male ; Female ; Heterocyclic Compounds, 2-Ring
Czasopismo naukowe
Tytuł:
Rationalizing artemisinin-based combination therapies use for treatment of uncomplicated malaria: A situation analysis in health facilities and private pharmacies of Douala 5e-Cameroon.
Autorzy:
Eboumbou Moukoko CE; Department of Biological Sciences, Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon.; Malaria Research Unit, Centre Pasteur Cameroon, Yaoundé, Cameroon.; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, The University of Douala, Douala, Cameroon.
Etang J; Department of Biological Sciences, Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon.; Yaoundé Research Institut, Organisation de Coordination pour la Lutte Contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Kojom Foko LP; Department of Animal Biology, Faculty of Science, The University of Douala, Douala, Cameroon.
Tafock CD; Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon.
Epee Eboumbou P; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, The University of Douala, Douala, Cameroon.; Clinical Sciences Department, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.; Pediatric wards, Bonassama Hospital, Douala, Cameroon.
Essangui Same EG; Department of Biological Sciences, Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon.; Laboratory of Parasitology, Mycology and Virology, Postgraduate Training Unit for Health Sciences, Postgraduate School for Pure and Applied Sciences, The University of Douala, Douala, Cameroon.
Penda IC; Clinical Sciences Department, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Same Ekobo A; Department of Biological Sciences, Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon.; National Roll Back Malaria Committee, Yaoundé, Cameroon.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 May 07; Vol. 19 (5), pp. e0299517. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Artemisinins*/therapeutic use
Antimalarials*/therapeutic use
Malaria*/drug therapy
Pharmacies*
Health Facilities*
Humans ; Cameroon ; Cross-Sectional Studies ; Female ; Male ; Adult ; Prospective Studies ; Drug Therapy, Combination ; Middle Aged ; Young Adult ; Adolescent
Czasopismo naukowe
Tytuł:
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
Autorzy:
James LP; PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Klaassen F; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Sweeney S; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Furin J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Yaesoubi R; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.
Chesov D; Discipline of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chişinǎu, Moldova.; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
Ciobanu N; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.
Codreanu A; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.
Crudu V; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.
Cohen T; Department of Epidemiology and Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Menzies NA; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2024 May 03; Vol. 21 (5), pp. e1004401. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Cost-Benefit Analysis*
Rifampin*/therapeutic use
Rifampin*/economics
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/economics
Quality-Adjusted Life Years*
Antitubercular Agents*/therapeutic use
Antitubercular Agents*/economics
Moxifloxacin*/therapeutic use
Moxifloxacin*/economics
Humans ; Moldova ; Adult ; Male ; Female ; Models, Theoretical ; Drug Therapy, Combination ; Linezolid/therapeutic use ; Linezolid/economics ; Diarylquinolines/therapeutic use ; Diarylquinolines/economics ; Middle Aged ; Treatment Outcome ; Drug Administration Schedule ; Adolescent ; Mycobacterium tuberculosis/drug effects
Czasopismo naukowe
Tytuł:
Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
Autorzy:
Lin YH; Department of Endocrinology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Zhang ZJ; Department of Endocrinology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Zhong JQ; Department of Laboratory Medicine, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Wang ZY; Department of Endocrinology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Peng YT; Department of Endocrinology, Zhongshan Hospital Xiamen University, Xiamen, Fujian, China.
Lin YM; Department of Endocrinology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Zhang HP; Department of Ultrasound, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Tian JQ; Department of Endocrinology, Xiamen Humanity Hospital, Fujian Medical University, Xiamen, Fujian, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 May 03; Vol. 19 (5), pp. e0302155. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial Protocol
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/drug therapy
Non-alcoholic Fatty Liver Disease*/complications
Glucosides*/therapeutic use
Glucosides*/adverse effects
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/complications
Glucagon-Like Peptides*/therapeutic use
Benzhydryl Compounds*/therapeutic use
Benzhydryl Compounds*/adverse effects
Humans ; Middle Aged ; Male ; Double-Blind Method ; Female ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/adverse effects ; Adult ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Drug Therapy, Combination ; Blood Glucose/metabolism ; Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Comparative evaluation of intensified short course regimen and standard regimen for adults TB meningitis: a protocol for an open label, multi-center, parallel arms, randomized controlled superiority trial (INSHORT trial).
Autorzy:
Inbaraj LR; Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chethpet, Chennai, 600031, India. .
Manesh A; Department of Infectious Diseases, Christian Medical College, Vellore, India.
Ponnuraja C; Department of Statistics, ICMR- National Institute for Research in Tuberculosis, Chethpet, Chennai, 600031, India.
Bhaskar A; Department of Statistics, ICMR- National Institute for Research in Tuberculosis, Chethpet, Chennai, 600031, India.
Srinivasalu VA; Department of Clinical Research, ICMR- National Institute for Research in Tuberculosis, Chethpet, Chennai, 600031, India.
Daniel BD; Department of Statistics, ICMR- National Institute for Research in Tuberculosis, Chethpet, Chennai, 600031, India. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 May 02; Vol. 25 (1), pp. 294. Date of Electronic Publication: 2024 May 02.
Typ publikacji:
Journal Article; Clinical Trial Protocol
MeSH Terms:
Tuberculosis, Meningeal*/drug therapy
Antitubercular Agents*/administration & dosage
Antitubercular Agents*/adverse effects
Antitubercular Agents*/therapeutic use
Multicenter Studies as Topic*
Humans ; India ; Isoniazid/administration & dosage ; Isoniazid/therapeutic use ; Drug Therapy, Combination ; Adult ; Rifampin/administration & dosage ; Rifampin/therapeutic use ; Equivalence Trials as Topic ; Treatment Outcome ; Drug Administration Schedule ; Randomized Controlled Trials as Topic ; Time Factors ; Pyrazinamide/administration & dosage ; Pyrazinamide/therapeutic use ; Aspirin/administration & dosage ; Aspirin/therapeutic use
Czasopismo naukowe
Tytuł:
Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study.
Autorzy:
An JH; Department of Veterinary Emergency and Critical Care Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National University, Chuncheon-si, Republic of Korea.
Choi HS; Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Gwanak-gu, Seoul, Republic of Korea.
Choi JS; Daewoong Pharmaceutical, Life Science Institute, Yongin, Gyeonggi-do, Republic of Korea.
Lim HW; Daewoong Pharmaceutical, Life Science Institute, Yongin, Gyeonggi-do, Republic of Korea.
Huh W; Daewoong Pharmaceutical, Life Science Institute, Yongin, Gyeonggi-do, Republic of Korea.
Oh YI; Department of Veterinary Internal Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
Park JS; Daewoong Pharmaceutical, Life Science Institute, Yongin, Gyeonggi-do, Republic of Korea.
Han J; Daewoong Pharmaceutical, Life Science Institute, Yongin, Gyeonggi-do, Republic of Korea.
Lim S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Lim CY; Nowon 24 hours N Animal Medical Center, Nowon-gu, Seoul, Republic of Korea.
Kim TH; Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Gwanak-gu, Seoul, Republic of Korea.
Moon JB; Daewoong pet, Boneunsa-ro, Gangnam-gu, Seoul, Republic of Korea.
Youn HY; Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Gwanak-gu, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2024 May; Vol. 10 (3), pp. e1454.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial, Veterinary
MeSH Terms:
Sodium-Glucose Transporter 2 Inhibitors*/administration & dosage
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Dog Diseases*/drug therapy
Insulin*
Hypoglycemic Agents*/administration & dosage
Benzofurans*
Animals ; Dogs ; Pilot Projects ; Male ; Female ; Drug Therapy, Combination/veterinary ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/veterinary
Czasopismo naukowe
Tytuł:
Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial.
Autorzy:
Tempark T; Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Shem A; M. Yamin Clinic and Pharmacy JI. M. Yamin, Samarinda, Indonesia.
Lueangarun S; Department of Aesthetic Medicine, College of Integrative Medicine, Dhurakij Pundit University, Bangkok, Thailand.; Division of Dermatology, DeMed Clinic Center, Bangkok, Thailand.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 May; Vol. 23 (5), pp. 1758-1765. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Comparative Study
MeSH Terms:
Acne Vulgaris*/drug therapy
Niacinamide*/administration & dosage
Niacinamide*/adverse effects
Skin Cream*/administration & dosage
Skin Cream*/adverse effects
Ceramides*/administration & dosage
Severity of Illness Index*
Administration, Cutaneous*
Dermatologic Agents*/administration & dosage
Dermatologic Agents*/adverse effects
Adapalene*/administration & dosage
Humans ; Double-Blind Method ; Female ; Male ; Young Adult ; Adult ; Treatment Outcome ; Adolescent ; Benzoyl Peroxide/administration & dosage ; Benzoyl Peroxide/adverse effects ; Drug Therapy, Combination ; Emollients/administration & dosage ; Drug Combinations
Czasopismo naukowe
Tytuł:
Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.
Autorzy:
Ocan M; Department of Pharmacology & Therapeutics, Makerere University College of Health Sciences, P. O. Box 7072, Kampala, Uganda. .
Nakalembe L; Department of Pharmacology, Soroti University, P. O. Box 211, Soroti, Uganda.
Otike C; Data Department, Joint Clinical Research Centre, Lubowa, P. O Box 10005, Kampala, Uganda.
Mordecai T; Makerere University College of Health Sciences Grants Office, P. Box 7072, Kampala, Uganda.
Birungi J; Department of Molecular Biology and Immunology, Makerere University College of Health Sciences, P. O. Box 7072, Kampala, Uganda.
Nsobya S; Department of Pathology, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2024 Apr 30; Vol. 23 (1), pp. 128. Date of Electronic Publication: 2024 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
Artemisinins*/therapeutic use
Antimalarials*/therapeutic use
Health Services Accessibility*/statistics & numerical data
Malaria*/drug therapy
Uganda ; Humans ; Cross-Sectional Studies ; Male ; Female ; Adult ; Young Adult ; Middle Aged ; Adolescent ; Drug Therapy, Combination ; Surveys and Questionnaires ; Aged
Czasopismo naukowe
Tytuł:
Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Autorzy:
Ji M; Department of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China.
Feng J; Department of Traditional Chinese Medicine, Shandong Wendeng Osteopath Hospital, Weihai, Shandong Province, China.
Liu G; Department of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 26; Vol. 19 (4), pp. e0299020. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024).
Typ publikacji:
Journal Article; Systematic Review; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Aripiprazole*/therapeutic use
Aripiprazole*/adverse effects
Bupropion*/therapeutic use
Bupropion*/adverse effects
Bupropion*/administration & dosage
Depressive Disorder, Major*/drug therapy
Randomized Controlled Trials as Topic*
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Treatment Outcome ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial.
Autorzy:
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Liu QF; Department of Hematology, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou, China.
Wu DP; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Soochow, China.
Xu ZL; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Han TT; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Sun YQ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Department of Hematology, Beijing Ludaopei Hematology Hospital, Beijing, China.
Huang F; Department of Hematology, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou, China.
Fan ZP; Department of Hematology, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou, China.
Xu N; Department of Hematology, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou, China.
Chen F; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Soochow, China.
Zhao Y; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Soochow, China.
Kong Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Department of Hematology, Beijing Ludaopei Hematology Hospital, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China. .; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. .; State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Apr 25; Vol. 22 (1), pp. 176. Date of Electronic Publication: 2024 Apr 25.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III
MeSH Terms:
Graft vs Host Disease*/drug therapy
Methotrexate*/administration & dosage
Methotrexate*/therapeutic use
Methylprednisolone*/therapeutic use
Methylprednisolone*/administration & dosage
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Female ; Male ; Middle Aged ; Adult ; Young Adult ; Treatment Outcome ; Drug Therapy, Combination ; Aged ; Adolescent ; Acute Disease
Czasopismo naukowe
Tytuł:
Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease.
Autorzy:
Yi LX; National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
Tan EK; National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.; Department of Neurology, Singapore General Hospital, Outram Road, Singapore 169608, Singapore.; Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore 169857, Singapore.
Zhou ZD; National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.; Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, Singapore 169857, Singapore.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 24; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Parkinson Disease*/drug therapy
Parkinson Disease*/metabolism
Tyrosine 3-Monooxygenase*/metabolism
Dopamine Agonists*/therapeutic use
Dopamine Agonists*/pharmacology
Humans ; Animals ; Drug Therapy, Combination ; Enzyme Inhibitors/therapeutic use ; Enzyme Inhibitors/pharmacology ; Dopaminergic Neurons/drug effects ; Dopaminergic Neurons/metabolism ; Dopamine/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies